About

About VivoSphere LLC At VivoSphere, we address a critical industry challenge: the early-stage identification of ineffective or toxic drug candidates to prevent costly failures in clinical trials. With VivoSphere technology, we create more human-like tissue models for more human-like drug responses. By offering three-dimensional tissue-engineered models that mimic human physiological responses more closely than traditional two-dimensional cell cultures, VivoSphere empowers pharmaceutical companies to improve the safety and efficacy of therapeutics, reduce reliance on animal testing, and make more informed decisions faster while reducing costs.